Haplotype structure of the beta adrenergic receptor genes in US Caucasians and African Americans

European Journal of Human Genetics

Volumn 13, Issue 3, 2005, Pages 341-351

  Belfer, Inna ^a   Buzas, Beata ^a   Evans, Catherine ^a   Hipp, Heather ^a   Phillips, Gabriel ^a   Taubman, Julie ^a   Lorincz, Ilona ^a   Lipsky, Robert H ^a   Enoch, Mary Anne ^a   Max, Mitchell B ^a   Goldman, David ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

ADRB1, ADRB2, ADRB3; Beta adrenergic receptors; Haplotype; Linkage disequilibrium; Single nucleotide polymorphism

Indexed keywords

BETA ADRENERGIC RECEPTOR;

AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DENSITY; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENE MAPPING; GENE STRUCTURE; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; LINKAGE ANALYSIS; MARKER GENE; MOLECULAR EVOLUTION; POPULATION RESEARCH; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UNITED STATES;

AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA; UNITED STATES;

EID: 20144372358     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201313     Document Type: Article

References (43)

1. De Blasi A: Beta-adrenergic receptors: structure, function and regulation. Drugs Exp Clin Res 1990; 16: 107-112.
2. Arner P: Adrenergic receptor function in fat cells. Am J Clin Nutr 1992; 55: 228S-236S.
3. Tashkin DP, Conolly ME, Deutsch RI, Hui KK, Littner M, Scarpace P: Subsensitization of beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjects. Am Rev Respir Dis 1982; 125: 185-193.
4. Rozec B, Noireaud J, Trochu JN, Gauthier C: Place of beta 3-adrenoceptors among other beta-adrenoceptor subtypes in the regulation of the cardiovascular system. Arch Mal Coeur Vaiss 2003; 96: 905-913.
5. Strosberg AD: Structure, function, and regulation of the three beta-adrenergic receptors. Obes Res 1995; 3: 501S-505S.
6. Maqbool A, Hall AS, Ball SG, Balmforth AJ: Common polymorphisms of β1-adrenoceptor: identification and rapid screening assay. Lancet 1999; 353: 897.
7. Wagoner LE, Craft LL, Zengel P et al: Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure. Am Hear J 2002; 144: 840-846.
8. Iwai C, Akita H, Shiga N et al: Suppressive effect of the Gly389 allele of the beta1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy. Circ J 2002; 66: 723-728.
9. Stanton T, Inglis GC, Padmanabhan S, Dominiczak AF, Jardine AG, Connell JM: Variation at the beta-1 adrenoceptor gene locus affects left ventricular mass in renal failure. J Nephrol 2002; 15: 512-518.
10. Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF: Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 2003; 74: 44-52.
11. Xie HG, Dishy V, Sofowora G et al: Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 2001; 11: 191-197.
12. O'Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ: The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. Clin Sci (Lond) 2000; 99: 233-238.
13. Ryden M, Hoffstedt J, Eriksson P, Bringman S, Arner P: The Arg 389 Gly beta1-adrenergic receptor gene polymorphism and human fat cell lipolysis. Int J Obes Relat Metab Disord 2001; 25: 1599-1603.
14. Dionne IJ, Garant MJ, Nolan AA et al: Association between obesity and a polymorphism in the beta(1)-adrenoceptor gene (Gly389Arg ADRB1) in Caucasian women. Int J Obes Relat Metab Disord 2002; 26: 633-639.
15. Reihsaus E, Innis M, MacIntyre N, Liggett SB: Mutations in the gene encoding for β2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8: 334-339.
16. Tomaszewski M, Brain NJ, Charchar FJ et al: Essential hypertension and beta2-adrenergic receptor gene: linkage and association analysis. Hypertension 2002; 40: 286-291.
17. Yoshida N, Nishimaki Y, Sugiyama M et al: SNP genotyping in the beta(2)-adrenergic receptor by electronic microchip assay, DHPLC, and direct sequencing. J Hum Genet 2002; 47: 500-503.
18. Green SA, Turki J, Hall IP, Liggett SB: Implications of genetic variability of human beta 2-adrenergic receptor structure. Pulm Pharmacol 1995; 8: 1-10.
19. Ellsworth DL, Coady SA, Chen W et al: Influence of the beta2-adrenergic receptor Arg16Gly polymorphism on longitudinal changes in obesity from childhood through young adulthood in a biracial cohort: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 2002; 26 928-937.
20. Garenc C, Perusse L, Chagnon YC et al: Effects of beta2-adrenergic receptor gene variants on adiposity: the HERITAGE Family Study. Obes Res 2003; 11: 612-618.
21. Chang TJ, Tsai MH, Jiang YD et al: The Arg16Gly polymorphism of human beta2-adrenoreceptor is associated with type 2 diabetes in Taiwanese people. Clin Endocrinol (Oxf) 2002; 57: 685-690.
22. Buscher R, Eilmes KJ, Grasemann H et al: Beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease. Pharmacogenetics 2002; 12: 347-353.
23. Jindra A, Horky K, Peleska J et al: Association analysis of Arg16Gly polymorphism of the beta2-adrenergic receptor gene in offspring from hypertensive and normotensive families. Blood Press 2002; 11: 213-217.
24. Bruck H, Leineweber K, Buscher R et al: The Gln27Glu beta2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivo. Pharmacogenetics 2003; 13 59-66.
25. Taylor DR, Kennedy MA: Genetic variation of the beta(2)-adrenoceptor: its functional and clinical importance in bronchial asthma. Am J Pharmacogenomics 2001; 1: 165-174.
26. Shachor J, Chana Z, Varsano S et al: Genetic polymorphisms of the beta-2 adrenergic receptor in Israelis with severe asthma compared to non-asthmatic Israelis. Isr Med Assoc J 2003; 5: 821-824.
27. Iwamoto N, Ogawa Y, Kajihara S et al: Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver. Clin Chim Acta 2001; 314: 85-91.
28. Gonzalez Sanchez JL, Proenza AM, Martinez Larrad MT et al The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain. Clin Endocrinol (Oxf) 2003; 59: 476-481.
29. Duarte NL, Colagiuri S, Palu T, Wang XL, Wilcken DE: Obesity, Type II diabetes and the beta 2 adrenoceptor gene Gln27Glu polymorphism in the Tongan population. Clin Sci (Lond) 2003; 104: 211-215.
30. Walston J, Silver K, Bogardus C et al: Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med 1995; 333: 343-347.
31. Yoshida N, Sakane N, Umekawa T: Mutation of beta-3-adrenergic-receptor gene and response to treatment of obesity. Lancet 1995; 346: 1433-1434.
32. Li LS, Lonnqvist F, Luthman H, Arner P: Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 1996; 39: 857-860.
33. Gabriel SB, Schaffner SF, Nguyen H et al: The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
34. Shi MM, Myrand SP, Bleavins MR, de la Iglesla FA: High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes. Mol Pathol 1999; 52: 295-299.
35. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
36. Long JC, Williams RC, Urbanek M: An E-M algorithm and testing strategy for multiple locus haplotypes. Am J Hum Genet 1995; 56 799-810.
37. Ke X, Cardon L: Efficient selective screening of haplotype tag SNPs. Bioinformatics 2003; 19: 287-288.
38. Maqbool A, Hall AS, Ball SG, Balmforth AJ: Common polymorphisms of beta1-adrenoceptor: identification and rapid screening assay. Lancet 1999; 353: 897.
39. Tesson F, Charron P, Peuchmaurd M et al: Characterization of a unique genetic variant in the beta 1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. J Mol Cell Cardiol 1999; 5: 1025-1032.
40. Lynch RA, Wagoner L, Li S, Sparks L, Molkentin J, Dorn JW: Novel and nondetected human signaling protein polymorphisms. Physiol Genomics 2002; 10: 159-168.
41. Yoshida N, Nishimaki Y, Sugiyama M et al: SNP genotyping in the beta(2)-adrenergic receptor by electronic microchip assay, DHPLC, and direct sequencing. J Hum Genet 2002; 47: 500-503.
42. Borjesson M, Magnusson Y, Hjalmarson A, Andersson B: A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J 2000; 22: 1853-1858.
43. Silver K, Walston J, Yang Y et al: Molecular scanning of the beta-3-adrenergic receptor gene in Pima Indians and Caucasians. Diabetes Metab Res Rev 1999; 15: 175-180.